Has anyone here made the jump from a DOE site to private labs while staying hands-on with radiochem? I’ve spent 6 years doing alpha/gamma spec and actinide separations in gloveboxes and hot cells (e.g., Pu-239/240 by TRU resin and electrodeposition), with strict ALARA/RWP practice, and I’m unsure how to frame this for pharma or environmental roles — are any teams hiring for this skillset right now?
Translate your 6 years of glovebox/hot-cell work and “TRU resin + electrodeposition” into GMP QC language — hot cell ops, contamination control, and alpha/gamma spec for batch release… Apply to radiopharma QC/radiochem teams (Novartis RLT, Curium) and mirror posts with GMP/validation/CAPA; start here: https://careers.novartis.com/search-jobs?keywords=radioligand. If pharma drags, environmental radioanalytical labs snap up actinide separations — do you have any GMP or aseptic exposure you can point to?
Quick step: building on @carmenl32, rewrite a resume bullet as ‘maintained contamination control and traceability under SOPs, trended MDA/uncertainty via control charts, and led CAPA-style investigations’ and target radiopharma QC (Curium, SOFIE, NorthStar) or NELAP labs like Pace… If you can quantify turnaround and limits of detection you already read as GMP/17025, batch records with a Geiger counter.
What got me traction moving out of a DOE lab was reframing one assay as an ‘ICH Q2 validation’ — accuracy/precision, LOD/LOQ, system suitability — and naming IQ/OQ/PQ on the instruments so it read GMP-ready. If you’re leaning environmental, swap that to ‘ISO 17025’ with chain-of-custody and PT/traceability; MARLAP helps translate methods to that language: https://www.epa.gov/radiation/marlap-manual. Do you have a PT or interlab comparison you can cite?
I got traction by turning one Pu‑239/240 TRU‑resin/electrodeposition assay into a 1‑page ‘method transfer’ that maps your DOE SOP to ISO 17025 — chain of custody, spike recovery, uncertainty budget — and bringing a redacted CoC to interviews. Do you have any ISO 17025 or NELAP audit notes you can reference? For environmental roles, translate MDC to ‘MDL per 40 CFR 136’ with your actual numbers and use this directory to target labs: https://nelac-institute.org; keep RWP/ALARA secondary and lead with data integrity.
Reframe one glovebox assay as “lot‑release QC” and spell out instruments and outcomes — e.g., Ortec HPGe efficiency checks within 1%, MDA targets met, zero cross‑contam events, and annual dose kept to X mrem under ALARA… That gives hiring managers concrete risk/control signals that transfer well, building on @lauras92 — it’s mostly translating acronyms, not reinventing chemistry. Which instruments have you run so folks can map you to roles?
Building on @david_kim34, package one Pu‑239/240 TRU‑resin/electrodeposition run as a mock ‘batch record’ — inputs, step sign‑offs, acceptance criteria (blank below MDA; spike recovery 95–105%), plus a one‑paragraph deviation/CAPA from a bad plate — and link it on your resume; pharma QC and NELAP labs read that instantly as hands‑on plus quality. Are you leaning pharma or environmental so you can tune the language?
But after 6 years in gloveboxes and hot cells, turn one actinide separation into a mini validation pack mapped to cGMP — IQ/OQ/PQ, acceptance criteria (MDA, background trending), and a brief deviation/CAPA — then translate “ALARA/RWP” into “ALCOA+” data integrity; , that framing gets callbacks. Pharma may care more about C‑14/T than alpha/gamma, but the rigor transfers, and if you’re open to radiopharm QC or DoD‑ELAP environmental labs, both keep you hands‑.